• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体外骨保护素基因治疗在预防磨损颗粒诱导的骨溶解中的疗效。

Efficacy of ex vivo OPG gene therapy in preventing wear debris induced osteolysis.

作者信息

Goater J Jeffrey, O'Keefe Regis J, Rosier Randy N, Puzas J Edward, Schwarz Edward M

机构信息

Department of Orthopaedics, The Center for Musculoskeletal Research, University of Rochester Medical Center, NY 14642, USA.

出版信息

J Orthop Res. 2002 Mar;20(2):169-73. doi: 10.1016/S0736-0266(01)00083-3.

DOI:10.1016/S0736-0266(01)00083-3
PMID:11918293
Abstract

Aseptic loosening of prosthetic implants remains a serious orthopaedic problem and the greatest limitation to total joint arthroplasty. Central to the etiology of aseptic loosening is periprosthetic osteolysis at the bone-implant interface, which is caused by wear debris-induced inflammation. This inflammation produces the critical osteoclast differentiation factor RANKL, which directly stimulates osteoclastogenesis and osteoclastic bone resorption. A dominant factor known to counteract this process is the natural RANKL receptor antagonist protein OPG. Here we explore the potential of ex vivo OPG gene therapy for aseptic loosening by evaluating the eflicacy of stably transfected fibroblast-like synoviocytes (FLS) expressing OPG in preventing wear debris-induced osteoclastogenesis, in a mouse calvaria model. Although the stably transfected fibroblasts produced small amounts of OPG (0.3 ng/ml/72 h/10(6) cells), this protein was very effective in preventing osteoclastic resorption as determined in a bone wafer assay. More importantly. implantation of 10(7) FLS-OPG, together with 30 mg of Ti wear debris, onto the calvaria of mice, completely inhibited osteoclastogenesis 3 days after surgery. Animals given FLS-LacZ control cells, which persisted for 3 days as determined by X-gal staining, together with the Ti particles, had a 6-fold increase in osteoclastogenesis compared to controls without Ti. This increased osteoclastogenesis was completely inhibited by the FLS-OPG, as osteoclast numbers in the calvaria of these animals were similar to that seen in the SHAM controls.

摘要

假体植入物的无菌性松动仍然是一个严重的骨科问题,也是全关节置换术的最大限制因素。无菌性松动病因的核心是骨-植入物界面处的假体周围骨溶解,这是由磨损颗粒诱导的炎症引起的。这种炎症产生关键的破骨细胞分化因子RANKL,它直接刺激破骨细胞生成和破骨细胞性骨吸收。已知对抗这一过程的一个主要因素是天然的RANKL受体拮抗剂蛋白OPG。在这里,我们通过在小鼠颅骨模型中评估稳定转染表达OPG的成纤维细胞样滑膜细胞(FLS)在预防磨损颗粒诱导的破骨细胞生成方面的效果,探讨离体OPG基因治疗无菌性松动的潜力。尽管稳定转染的成纤维细胞产生少量的OPG(0.3 ng/ml/72 h/10⁶个细胞),但在骨片分析中确定,这种蛋白在预防破骨细胞性吸收方面非常有效。更重要的是,将10⁷个FLS-OPG与30 mg钛磨损颗粒一起植入小鼠颅骨,在手术后3天完全抑制了破骨细胞生成。给予FLS-LacZ对照细胞(通过X-gal染色确定其持续存在3天)与钛颗粒的动物,与没有钛颗粒的对照组相比,破骨细胞生成增加了6倍。这种增加的破骨细胞生成被FLS-OPG完全抑制,因为这些动物颅骨中的破骨细胞数量与假手术对照组相似。

相似文献

1
Efficacy of ex vivo OPG gene therapy in preventing wear debris induced osteolysis.体外骨保护素基因治疗在预防磨损颗粒诱导的骨溶解中的疗效。
J Orthop Res. 2002 Mar;20(2):169-73. doi: 10.1016/S0736-0266(01)00083-3.
2
Adeno-associated virus-mediated osteoprotegerin gene transfer protects against particulate polyethylene-induced osteolysis in a murine model.腺相关病毒介导的骨保护素基因转移可在小鼠模型中预防颗粒性聚乙烯诱导的骨溶解。
Arthritis Rheum. 2002 Sep;46(9):2514-23. doi: 10.1002/art.10527.
3
Recombinant adeno-associated virus-mediated osteoprotegerin gene therapy inhibits wear debris-induced osteolysis.重组腺相关病毒介导的骨保护素基因治疗抑制磨损颗粒诱导的骨溶解。
J Bone Joint Surg Am. 2002 Aug;84(8):1405-12. doi: 10.2106/00004623-200208000-00016.
4
Quantitative small-animal surrogate to evaluate drug efficacy in preventing wear debris-induced osteolysis.用于评估药物预防磨损颗粒诱导的骨溶解疗效的定量小动物替代指标。
J Orthop Res. 2000 Nov;18(6):849-55. doi: 10.1002/jor.1100180602.
5
Viral interleukin-10 gene inhibition of inflammation, osteoclastogenesis, and bone resorption in response to titanium particles.病毒白细胞介素-10基因对钛颗粒引发的炎症、破骨细胞生成及骨吸收的抑制作用。
Arthritis Rheum. 2002 May;46(5):1298-308. doi: 10.1002/art.10227.
6
In vivo RANK signaling blockade using the receptor activator of NF-kappaB:Fc effectively prevents and ameliorates wear debris-induced osteolysis via osteoclast depletion without inhibiting osteogenesis.使用核因子κB受体激活剂:Fc在体内阻断RANK信号传导,可通过减少破骨细胞而有效预防和改善磨损颗粒诱导的骨溶解,且不抑制骨生成。
J Bone Miner Res. 2002 Feb;17(2):192-9. doi: 10.1359/jbmr.2002.17.2.192.
7
Suppression of polyethylene particle-induced osteolysis by exogenous osteoprotegerin.外源性骨保护素对聚乙烯颗粒诱导的骨溶解的抑制作用
J Biomed Mater Res A. 2005 Nov 1;75(2):288-94. doi: 10.1002/jbm.a.30441.
8
Efficacy of etanercept for wear debris-induced osteolysis.依那西普对磨损颗粒诱导的骨溶解的疗效。
J Bone Miner Res. 2001 Feb;16(2):338-47. doi: 10.1359/jbmr.2001.16.2.338.
9
Evidence for a direct role of cyclo-oxygenase 2 in implant wear debris-induced osteolysis.环氧化酶2在植入物磨损颗粒诱导的骨溶解中直接作用的证据。
J Bone Miner Res. 2001 Apr;16(4):660-70. doi: 10.1359/jbmr.2001.16.4.660.
10
Tumor necrosis factor-alpha/nuclear transcription factor-kappaB signaling in periprosthetic osteolysis.肿瘤坏死因子-α/核转录因子-κB信号通路与假体周围骨溶解
J Orthop Res. 2000 May;18(3):472-80. doi: 10.1002/jor.1100180321.

引用本文的文献

1
Naringin increases osteoprotegerin expression in fibroblasts from periprosthetic membrane by the Wnt/β-catenin signaling pathway.柚皮苷通过 Wnt/β-连环蛋白信号通路增加假体周围膜成纤维细胞中骨保护素的表达。
J Orthop Surg Res. 2020 Dec 10;15(1):600. doi: 10.1186/s13018-020-02145-z.
2
Elevation of the unfolded protein response increases RANKL expression.未折叠蛋白反应的增强会增加核因子κB受体活化因子配体(RANKL)的表达。
FASEB Bioadv. 2020 Jan 31;2(4):207-218. doi: 10.1096/fba.2019-00032. eCollection 2020 Apr.
3
NF-κB decoy oligodeoxynucleotide inhibits wear particle-induced inflammation in a murine calvarial model.
核因子κB诱饵寡脱氧核苷酸抑制小鼠颅骨模型中磨损颗粒诱导的炎症。
J Biomed Mater Res A. 2015 Dec;103(12):3872-8. doi: 10.1002/jbm.a.35532. Epub 2015 Jul 14.
4
Gene Therapy for Cartilage Repair.基因治疗在软骨修复中的应用。
Cartilage. 2011 Jul;2(3):201-25. doi: 10.1177/1947603510392914.
5
Pharmacologic augmentation of implant fixation in osteopenic bone.在骨质疏松性骨中增强植入物固定的药理学方法。
Curr Osteoporos Rep. 2014 Mar;12(1):55-64. doi: 10.1007/s11914-013-0182-z.
6
Periprosthetic osteolysis after total hip replacement: molecular pathology and clinical management.全髋关节置换术后假体周围骨溶解:分子病理学与临床管理
Inflammopharmacology. 2013 Dec;21(6):389-96. doi: 10.1007/s10787-013-0192-6. Epub 2013 Oct 15.
7
Extracellular matrix degradation and tissue remodeling in periprosthetic loosening and osteolysis: focus on matrix metalloproteinases, their endogenous tissue inhibitors, and the proteasome.在假体松动和骨溶解中细胞外基质降解和组织重塑:聚焦基质金属蛋白酶、其内源性组织抑制剂和蛋白酶体。
Biomed Res Int. 2013;2013:230805. doi: 10.1155/2013/230805. Epub 2013 Jun 19.
8
Anti-oxidation treatment of ultra high molecular weight polyethylene components to decrease periprosthetic osteolysis: evaluation of osteolytic and osteogenic properties of wear debris particles in a murine calvaria model.超高分子量聚乙烯部件的抗氧化处理以减少假体周围溶骨:在小鼠颅骨模型中评估磨损颗粒的溶骨和成骨特性。
Curr Rheumatol Rep. 2013 May;15(5):325. doi: 10.1007/s11926-013-0325-3.
9
Local effect of IL-4 delivery on polyethylene particle induced osteolysis in the murine calvarium.IL-4 递送对小鼠颅骨聚乙烯颗粒诱导骨溶解的局部作用。
J Biomed Mater Res A. 2013 Jul;101(7):1926-34. doi: 10.1002/jbm.a.34486. Epub 2012 Dec 5.
10
Periprosthetic osteolysis: genetics, mechanisms and potential therapeutic interventions.假体周围骨溶解:遗传学、机制和潜在的治疗干预。
Can J Surg. 2012 Dec;55(6):408-17. doi: 10.1503/cjs.003711.